Suvorexant
Medication
Suvorexant, sold under the brand name Belsomra, is an orexin antagonist medication which is used in the treatment of insomnia. It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset and/or... Wikipedia
Addiction liability: Low
AHFS/Drugs.com: Monograph
Bioavailability: 82% (10 mg; lower at higher doses)
Elimination half-life: 12.2 hours (8–19 hours) (40 mg)
Metabolites: Hydroxysuvorexant (inactive)
Other names: MK-4305; MK4305